We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Sets out recommendations to speed up access to innovative healthcare and technologies, to improve efficiency and outcomes for NHS patients.
Proposals for accelerated access pathways for medicines, diagnostics, medical devices and digital products.
Outlines the main themes in stakeholders' feedback to the Accelerated Access Review interim report.
Looks at issues relating to the ethics of medicines adaptive pathways for patients (MAPPs) including the use of real world data.
Assesses the practicality of recommendations from the Accelerated Access Review interim report.
Recommendations to build on achievements of Early Access to Medicines Scheme and improve adoption of innovative medicines across the NHS.
Sir Hugh Taylor sets out 5 propositions to speed up access to transformative health technology that can change the lives of NHS patients.
International insights into emerging and effective practice in improving access to medicines and medical technology: study by Rand Europe.
Barriers to innovation in medicines and medicinal technology and the opportunities for improvement: a study by Deloitte and partners.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).